These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 23634737)

  • 1. New findings and old controversies in the research of multiple sclerosis and its model experimental autoimmune encephalomyelitis.
    Aharoni R
    Expert Rev Clin Immunol; 2013 May; 9(5):423-40. PubMed ID: 23634737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunomodulation neuroprotection and remyelination - the fundamental therapeutic effects of glatiramer acetate: a critical review.
    Aharoni R
    J Autoimmun; 2014 Nov; 54():81-92. PubMed ID: 24934599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early axonal damage and progressive myelin pathology define the kinetics of CNS histopathology in a mouse model of multiple sclerosis.
    Recks MS; Stormanns ER; Bader J; Arnhold S; Addicks K; Kuerten S
    Clin Immunol; 2013 Oct; 149(1):32-45. PubMed ID: 23899992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct pathological patterns in relapsing-remitting and chronic models of experimental autoimmune enchephalomyelitis and the neuroprotective effect of glatiramer acetate.
    Aharoni R; Vainshtein A; Stock A; Eilam R; From R; Shinder V; Arnon R
    J Autoimmun; 2011 Nov; 37(3):228-41. PubMed ID: 21752599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New insights into cell responses involved in experimental autoimmune encephalomyelitis and multiple sclerosis.
    El Behi M; Dubucquoi S; Lefranc D; Zéphir H; De Seze J; Vermersch P; Prin L
    Immunol Lett; 2005 Jan; 96(1):11-26. PubMed ID: 15585303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Ifng gene is essential for Vdr gene expression and vitamin D₃-mediated reduction of the pathogenic T cell burden in the central nervous system in experimental autoimmune encephalomyelitis, a multiple sclerosis model.
    Spanier JA; Nashold FE; Olson JK; Hayes CE
    J Immunol; 2012 Sep; 189(6):3188-97. PubMed ID: 22896638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclophilin D inactivation protects axons in experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis.
    Forte M; Gold BG; Marracci G; Chaudhary P; Basso E; Johnsen D; Yu X; Fowlkes J; Rahder M; Stem K; Bernardi P; Bourdette D
    Proc Natl Acad Sci U S A; 2007 May; 104(18):7558-63. PubMed ID: 17463082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic resonance imaging characterization of different experimental autoimmune encephalomyelitis models and the therapeutic effect of glatiramer acetate.
    Aharoni R; Sasson E; Blumenfeld-Katzir T; Eilam R; Sela M; Assaf Y; Arnon R
    Exp Neurol; 2013 Feb; 240():130-44. PubMed ID: 23153580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous neuroprotection and blockade of inflammation reverses autoimmune encephalomyelitis.
    Kanwar JR; Kanwar RK; Krissansen GW
    Brain; 2004 Jun; 127(Pt 6):1313-31. PubMed ID: 15130951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Astrocyte-associated axonal damage in pre-onset stages of experimental autoimmune encephalomyelitis.
    Wang D; Ayers MM; Catmull DV; Hazelwood LJ; Bernard CC; Orian JM
    Glia; 2005 Aug; 51(3):235-40. PubMed ID: 15812814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experimental allergic encephalomyelitis as an animal model for multiple sclerosis].
    Lukinović-Skudar V; Taradi SK; Andreis I; Zupancić V; Taradi M
    Lijec Vjesn; 2001; 123(3-4):81-8. PubMed ID: 11488222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic approach by Aloe vera in experimental model of multiple sclerosis.
    Mirshafiey A; Aghily B; Namaki S; Razavi A; Ghazavi A; Ekhtiari P; Mosayebi G
    Immunopharmacol Immunotoxicol; 2010 Sep; 32(3):410-5. PubMed ID: 20233107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Axonal and neuronal pathology in multiple sclerosis: what have we learnt from animal models.
    Lassmann H
    Exp Neurol; 2010 Sep; 225(1):2-8. PubMed ID: 19840788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prospects of minocycline in multiple sclerosis.
    Chen X; Ma X; Jiang Y; Pi R; Liu Y; Ma L
    J Neuroimmunol; 2011 Jun; 235(1-2):1-8. PubMed ID: 21565409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mechanism of action of glatiramer acetate in multiple sclerosis and beyond.
    Aharoni R
    Autoimmun Rev; 2013 Mar; 12(5):543-53. PubMed ID: 23051633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pattern of axonal injury in murine myelin oligodendrocyte glycoprotein induced experimental autoimmune encephalomyelitis: implications for multiple sclerosis.
    Herrero-Herranz E; Pardo LA; Gold R; Linker RA
    Neurobiol Dis; 2008 May; 30(2):162-73. PubMed ID: 18342527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiinflammatory activity of glucomoringin isothiocyanate in a mouse model of experimental autoimmune encephalomyelitis.
    Galuppo M; Giacoppo S; De Nicola GR; Iori R; Navarra M; Lombardo GE; Bramanti P; Mazzon E
    Fitoterapia; 2014 Jun; 95():160-74. PubMed ID: 24685508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-inflammatory effects of levetiracetam in experimental autoimmune encephalomyelitis.
    Thöne J; Ellrichmann G; Faustmann PM; Gold R; Haghikia A
    Int Immunopharmacol; 2012 Sep; 14(1):9-12. PubMed ID: 22691576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurodegeneration in autoimmune CNS inflammation.
    Herz J; Zipp F; Siffrin V
    Exp Neurol; 2010 Sep; 225(1):9-17. PubMed ID: 19961850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Future neuroprotective strategies.
    Sättler MB; Bähr M
    Exp Neurol; 2010 Sep; 225(1):40-7. PubMed ID: 19716365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.